ArticleFrontiers in oncology2025

Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer.

Chaokun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.